Navigation Links
Reportlinker Adds Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
Date:6/20/2011

NEW YORK, June 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

http://www.reportlinker.com/p0558484/Global-Microbiology-Testing-Market-US-Europe-Japan--Emerging-Opportunities-and-Business-Expansion-Strategies-for-Suppliers.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This comprehensive seven-country report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides market segmentation analysis of over 90 diseases and viruses in seven countries, assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.

Rationale

The microbiology testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing. Among the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Geographic Coverage

- France

- Germany

- Italy

- Japan

- Spain

- UK

- USA

Market Segmentation Analysis

- Sales and market shares of major suppliers of microbiology products, by country and individual test.

- Test and sales forecasts for over 90 microbiology assays by country, individual test and market segment:

- Hospitals

- Blood Banks

- Commercial/Private Laboratories

- Physician Offices/Group Practices

- Public Health Laboratories

- Review of market dynamics, trends, structure, size, growth and major suppliers by country.

Current and Emerging Products

- In-depth examination of over 90 major diseases, including etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for microbiology testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for microbiology testing.

- Extensive listings of companies developing or marketing microbiology products worldwide by individual test.

Competitive Assessments

- Detailed strategic assessments of 32 major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Worldwide Market Overview

- Estimated universe of laboratories performing microbiology tests by country.

- Test volume and sales projections for major microbiology assays by country.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation, reagents, IT and other products with significant market

appeal during the next ten years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group's proprietary data files was conducted.

Contains 1,900 pages and 820 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Microbiology Tests

1. AIDS

a. Background

0 Structure and Composition

0 Classification

0 Origin of AIDS

0 Animal Lentivirus Systems

0 Virus Receptos

0 HIV Infections in Humans

- Pathogenesis & Pathology: Overview of

HIV Infection Course

0 CD4T Lymphocytes and Memory Cells

0 Monocytes and Macrophages

0 Lymphoid Organs

0 Neural Cells

0 Viral Coinfections

- Clinical Findings

0 Plasma Viral Load

0 Pediatric AIDS

- Neurologic Disease

- Opportunistic Infections

- Cancer

0 Immunity

- Virus Isolation

- Serology

- Detection of Viral Nucleic

Acid and Antigens

0 Infectivity

0 Epidemiology

- Worldwide Spread of AIDS

- United States

- Routes of Transmission

b. Diagnostic Tests

0 Laboratory Diagnosis

- Enzyme Immunoassay Interpretation

- Specific, Sensitivity, and Predictive

Value of Enzyme Immunoassays

0 Competition Assays

0 Western Blot Technique

0 Immuno-Fluorescence Assay (IFA)

0 Radioimmunoprecipitation

0 HIV-1/HIV-2 Combination Testing

0 Methods of HIV-Antigen Detection

0 Antigen Assays and Blood Screening

0 Urine Tests

0 Immunopathogenic Mechanism of HIV Infection

0 DNA Probes

- Overview

- Quantitative Polymerase Chain Reaction

- In Situ PCR

- Needed Improvements

0 Viral Load/Drug Resistance Testing

0 Genotype and Phenotype Testing

0 Blood Banking Consideration

c. Vaccines and Drugs

- Antiviral Drugs

- Vaccines Against HIV

0 Transmission of HIV in Blood Products

0 HIV Transmission in Transplant and

Artificial Insemination Recipients

2. Adenovirus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

d. Adeno-Associated Viruses(AAV)

3. Aeromonas

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

4. Anthrax/Bacillus Anthracis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

5. Arboviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

6. Babesiosis

a. Background

7. Bacillary Epithelioid Angiomatosis (BEA)

And Other Bartonella (Rochalimaea)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

8. Blastocystis Hominis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

9. Brucella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

10. Campylobacter

a. Background

b. Diagnostic Tests

0 Identification from Culture

c. Vaccines and Drugs

11. Candida

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

12. Chagas Disease

a. Background

13. Chancroid

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

14. Chlamydia

a. Background

0 Chlamydia Psittaci

0 Chlamydia Pneumoniae

0 Chlamydia Trachomatis

b. Diagnostic Tests

c. Vaccines and Drugs

15. Clostridium Difficile

a. Background

0 Pediatric Infections

0 Epidemiology

b. Diagnostic Tests

0 Counterimmunoelectrophoresis

0 Fluorescent-Antibody Assays

0 Poloymerase Chain Reactions

c. Drugs and Vaccines

16. Coronaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

17. Coxsackieviruses

a. Background

0 Herpangina

0 Hand-foot-and-mouth syndrome

0 Hepidemic Conjuctivitis

0 Pharingitis

0 Epidemic Pleurodynia

0 Myodarditis,Pericarditis

0 Overwhelming Infection of the Newborn

0 Acute Aseptic Meningitis

0 Undifferentiated Febrile Illness

0 Fever with upper respiratory infection

0 Encephalitis

0 Asymptomatic Infection

b. Diagnostic Tests

c. Vaccines and Drugs

18. Creutzfeldt-Jakob's Disease

a. Background

0 Blood Transmission

b. Diagnostic Tests

0 Major Commercial and Academic Players

- Bayer

- Disease Sciences/Bio Tec Global

- Imperial College of Medicine

- Ortho-Clinical Diagnostics

- Pall

- ProMetic Life Sciences

- Proteome Sciences/Idexx

- Q-One Biotech

- Serono

- U.S. Agricultural Research Service

c. Vaccines

19. Cryptosporidium Parvum

a. Background

b. Diagnostic Tests

0 Histologic

0 Laboratory Parasitology

0 Serodiagnosis

c. Vaccines and Drugs

20. Cyclospora Cayetanensis

a. Background

0 Asymptomatic Infection

0 Diarrhea in Immunocompetent Persons

0 Diarrhea in Immunocompromisedersons

b. Diagnostic Tests

c. Vaccines and Drugs

21. Cytomegalovirus

a. Background

0 Chorioretinitis

0 Gastrointestinal

0 Central Nervous System Disease

b. Diagnostic Tests

c. Vaccines and Drugs

22. Ebola Virus

a. Background

0 Epidemiology

0 Hemorrhagic Fever

b. Diagnostic Tests

c. Vaccines and Drugs

23. E. Coli

a. Background

0 Role of Escherichia Coli in

Causing Diarrhea

0 EPEC

0 ETEC

0 EIEC

0 EHEC

b. Diagnostic Tests

c. Vaccines and Drugs

24. EchoVirus

a. Background

0 Acute Aseptic Miningitisis

0 Encephalitis

0 Exanthems

0 Respiratory Disease

0 Myope;ricarditis

0 Neonatal Infections

b. Diagnostic Tests

c. Vaccines and Drugs

25. Encephalitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

26. Enteroviruses

a. Background

b. Diagnostic Tests

0 Viral Isolation and Identification

0 Antibody Tests

c. Vaccines and Drugs

27. Epstein-Barr Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

28. Giardia Lamblia

a. Background

0 Life Cycle and Morphology

0 Morphology of Trophozoites

0 Clinical Disease

b. Diagnostic Tests

c. Vaccines and Drugs

29. Gonorrhea

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

30. Granuloma Inguinale

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

31. Hantavirus

a. Background

0 Identification of the Agent

0 Transmission

0 Other Rodent Hantaviruses

0 Distribution

0 Hantavirus Diseases

0 Epidemiology

0 Addendum in Proof-Northeastern Connection

0 Previously Unknown Pathogens

0 Cases Nationwide

b. Diagnostic Tests

0 An Immunohistochemistry Approach

0 Hantavirus Rapid Diagnostic Test

0 ELISA Diagnosis of Hantavirus Pulmonary

Syndrome

0 IgG ELISA

0 IgM Capture ELISA

c. Vaccines and Drugs

32. Helicobacter Pylori

a. Background

0 Pathogenesis

0 Role in Peptic Ulcer Disease

0 Role in Gastric Cancer

0 Nonulcer Dyspepsia

b. Diagnostic Tests

c. Vaccines and Drugs

0 Specific Therapeutic Regimens

0 Who Should Be Treated?

0 Participants in Controlled Clinical Trials

0 Patients with Refractory Peptic Ulcer

0 Patients with Refractory NUD

0 Patients in High-Risk Groups for Gastric

Cancer

33. Hepatitis

a. Background

b. Hepatitis A

c. Hepatitis B

d. Hepatitis C

0 Classification

0 Transmission of Infection

0 Occupational Hazards

0 Acute Hepatitis

0 Diagnosis of Acute Infection

0 Chronic Hepatitis

0 HCV and Other Chronic Liver Diseases

0 Alcoholic Liver Disease

0 Hepatitis B Coinfection

0 Cirrhosis and Hepatocellular Carcinoma

0 Diagnostic Tests

0 Possible Indications for HCV RNA Testing

0 Conclusions and Future Direction

e. Hepatitis D

0 Historical Perspective

0 Epidemiology

0 HBV-HDV "Coinfection" vs. "Superinfection"

0 Methods of Detecting HDV

0 Prevention

f. Hepatitis E

0 Background

0 Prevalence of the Disease

0 Diagnostic Tests

0 Epidemiologic Serosurveys

0 Serologic Cross-Reactivity

g. Hepatitis G

0 Vaccines and Drugs

34. Herpes Simplex Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

35. Human Herpes Virus-6 (HHV-6)

a. Background

0 HIV-6 Infections

b. Diagnostic Tests

c. Vaccines and Drugs

36. Influenza Viruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

37. Legionella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

38. Lyme Disease

a. Background

0 Clinical Description

0 Clinical Case Definition

0 Laboratory Criteria for Diagnosis

0 Case Classification

b. Diagnostic Tests

c. Vaccines and Drugs

39. Lymphogranuloma Venereum (LGV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

40. Malaria

a. Background

b. Diagnostic Tests

0 Potential Diagnostic Problems with Positive

Patients from Non-endemic Areas

- Patient

- Laboratory

- Physician

c. Vaccines and Drugs

41. Measles (Rubeola)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

42. Meningitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

0 Development of Polysaccharide Vaccines

0 Quadrivalent Vaccine Development

0 Meningococcal A.C.Y. & W-135 Vaccines

0 Efficacy of Group C Vaccine

0 Efficacy of Group A Vaccine

0 Combinations of Group A and C Vaccines

0 Group B Efficacy Trials

0 Future Direction

43. Microsporidium

a. Background

0 Prevalence and Geographic Distribution

0 Sources of Human Infection and Transmission

b. Diagnostic Tests

0 Light Microscopic Examination of Stool

Specimens By Chromotrope Staining

0 Stool Concentration Methods

0 Chemofluorescent Agents

0 Giemsa Staining of Stool Specimens

0 Cytologic Diagnosis

0 Histologic Examination

0 Electron Microscopy

0 Examination of Bodily Fluids

0 Examination of Tissue Sections

0 Immunofluorescence Detection Procedures

0 Serology

0 Cell Culture

0 Approach to Diagnosis

0 Evaluation of Patients with Presumptive

Intestinal Microsporidiosis

0 Evaluation of Patients with Presumptive

Ocular Microsporidiosis

c. Vaccines and Drugs

44. Mononucleosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

45. Mumps

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

0 Efficacy of Vaccination

0 Future Issues

46. Mycoplasma

a. Background

0 Ureaplasma Urealyticum & Mycoplasma Hominis

b. Diagnostic Tests

c. Vaccines and Drugs

47. Papillomaviruses

a. Background

0 HPV in Cancer

0 Cervical Neoplasm

b. Diagnostic Tests

c. Vaccines and Drugs

0 Prevention

48. Parvovirus B19

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

49. Pneumonia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

50. Polyomaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

51. Pseudomonas Aeruginosa

a. Background

0 Virulence Factors

b. Diagnostic Tests

c. Vaccines and Drugs

52. Rabies

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

53. Respiratory Syncytial Virus (RSV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

54. RhinoViruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

55. RotaVirus (REOVIRUS)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

56. Rubella(MEASLES)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

0 Developing Countries

0 Elimination and Eradication of Measles

0 New Developments

57. Salmonellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

58. Septicemia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

59. Shigellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

60. Staphylococcus Aureus

a. Background

0 The Genus Taphylococcus

b. Diagnostic Tests

c. Vaccines and Drugs

0 Prevention

61. Streptococci

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

0 Group A Streptococci

0 Group B Streptococci

62. Syphilis

a. Background

b. Diagnostic Tests

0 Biopsy

0 Rabbit Infectivity Testing

0 Other Diagnostic Modalities

c. Vaccines and Drugs

0 Syphilis and HIV Infection

0 Syphilis As a Cofactor for HIV Transmission

0 Basic Science Issues

63. Toxoplasmosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

64. Trichomonas Vaginalis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

65. Tuberculosis

a. Background

b. Diagnostic Tests

0 Microscopic Characteristics

0 Cultural Characteristics

0 Detection of Antibodies

0 Skin Tests

0 MDRTB

c. Vaccines and Drugs

66. Vibrio

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

67. West Nile Virus

a. Background

- Clinical Syndromes

b. Diagnostic Tests

c. Vaccines and Drugs

68. Yersina

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

B. Instrumentation Review and Market Needs

0 Abbott AxSYM

0 Abbott IMx/IMx Select

0 Anagen AN2000/AuraFlex

0 Beckman Coulter Access

0 BioChem Pharma/SR1

0 BioMerieux/Vitek Vidas

0 Biotrol System 7000

0 Chiron ACS: Centaur

0 Chiron ACS: 180

0 J&J Diagnostics/Amersham Amerlite

0 J&J Diagnostics Vitros ECi

0 Olympus PK310

0 Roche Cobas Core

0 Roche Elecsys 1010/2010

0 Roche ES 22

0 Roche ES 33

0 Roche ES 300/300AL

0 Siemens ELISA Processor II/III

0 Siemens Immuno 1

0 Siemens/Opus/Plus/Magnum

0 Siemens Stratus

0 Tosoh AIA-1200/1200DX/NexIA/600

0 Wallac/Pharmacia Delfia

C. Emerging Diagnostic Technologies

1. DNA Probes

a. Technology Overview

b. Amplification Methods

0 Polymerase Chain Reaction

- Robotics

- Temperature Cyclers

- PCR Variations

0 Immuno-PCR

0 QC-PCR

0 DAP-PCR

0 Ligase Chain Reaction

0 Branched DNA

0 Q-Beta Replicase

0 Nucleic-Acid Sequence-Based

0 Strand Displacement Activation

0 Self-Sustained Sequence Replicase

2. Monoclonal Antibodies

3. Immunoassays

a. Technological Principle

b. Enzyme Immunoassays (EIA)

0 Overview

0 ELISA

0 Dot Immunobinding Assays

0 Capillary Immunoassays

0 Particle-Membrane Capture

Immunoassays

0 Enzyme Amplification

c. Fluorescent Immunoassays

0 Fluorescence Polarization

0 Time-Resolved Pulse Fluorescence

d. Luminescence

0 Chemiluminescence

0 Bioluminescence

e. Latex Agglutination

f. Immunoprecipitation

4. Differential Light Scattering

5. Microcomputers and Automation

6. Artificial Intelligence

7. Liposomes

8. Flow Cytometry

9. Chromatography

10. MRI

11. Gel Microdroplets

12. Other

D. Business Environment

E. Market Structure

F. Market Size and Growth

G. Personal Testing

France

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Germany

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Italy

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Japan

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Spain

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth And Major Suppliers

U.K.

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth a+nd Major Suppliers

U.S.A.

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Reimbursement

4. Industry Consolidation

5. Managed Care

a. HMO

b. PPO

6. Hospitals

7. Admissions

8. Length of Stay

9. Industry Diversification

10. Physician Demographics

11. Population Aging

a. Chronic Illness

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

12. Laboratory Regulations

13. FDA Reform

C. Market Structure

1. Centralized Testing

a. Hospitals

b. Commercial/Private Laboratories

c. Blood Banks

1) Community and Regional Centers

2) Plasma Fractionation Centers

2. Decentralized Testing

a. Physician Offices/Group Practices

b. Point of Care Testing

c. Other Decentralized Testing Locations

D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

A. Instrumentation

B. Reagent Kits and Test Systems/panels

C. Computers, Software and Automation

D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized

Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Assessments

- Abbott

- Affymetrix

- Beckman Coulter

- Becton Dickinson

- bioMerieux

- Bio-Rad

- Cepheid

- Diamedix

- DiaSorin

- Eiken Chemical

- Enzo Biochem

- Fujirebio

- Gen-Probe

- Hologic

- ID Biomedical

- J&J Diagnostics

- Kreatech

- Life Technology

- Lonza

- Nanogen

- Novartis Diagnostics

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens

- Takara Bio

- Thermo Fisher

- Wallac

- Wako

Appendix: Assumed Currency Exchange Rates

List of Tables

Major Companies Developing or Marketing AIDS Tests

Major Companies Developing or Marketing Adenovirus

Tests

Major Companies Developing or Marketing Bartonella

Tests

Major Companies Developing or Marketing

Campylobacter Tests

Major Companies Developing or Marketing Candida

Tests

Major Companies Developing or Marketing Chlamydia

Tests

Major Companies Developing or Marketing Clostridium

Tests

Major Companies Developing or Marketing Coronavirus

Tests

Major Companies Developing or Marketing Cryptosporidium

Tests

Major Companies Developing or Marketing CMV Tests

Major Companies Developing or Marketing Echovirus

Tests

Major Companies Developing or Marketing Enterovirus

Tests

Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia

Tests

Major Companies Developing or Marketing Gonorrhea

Tests

Major Companies Developing or Marketing Hantavirus

Tests

Major Companies Developing or Marketing Helicobacter

Pylori Tests

Major Companies Developing or Marketing Hepatitis

Tests

Major Companies Developing or Marketing Herpes

Tests

Major Companies Developing or Marketing Influenza

Tests

Major Companies Developing or Marketing Legionella

Tests

Major Companies Developing or Marketing Lyme Disease

Tests

Major Companies Developing or Marketing Lymphogranuloma

Tests

Major Companies Developing or Marketing Malaria

Tests

Major Companies Developing or Marketing Measles

Tests

Major Companies Developing or Marketing Meningitis

Tests

Major Companies Developing or Marketing Microsporidium

Tests

Major Companies Developing or Marketing

Mononucleosis Tests

Major Companies Developing or Marketing Mumps Tests

Major Companies Developing or Marketing Mycoplasma

Tests

Major Companies Developing or Marketing Papilloma

Virus Tests

Major Companies Developing or Marketing Parvovirus

Tests

Major Companies Developing or Marketing Pneumonia

Tests

Major Companies Developing or Marketing RSV Tests

Major Companies Developing or Marketing Rotavirus

Tests

Major Companies Developing or Marketing Rubella

Tests

Major Companies Developing or Marketing Salmonella

Tests

Major Companies Developing or Marketing Septicemia

Tests

Major Companies Developing or Marketing Shigella

Tests

Major Companies Developing or Marketing Staphylococci

Tests

Major Companies Developing or Marketing

Streptococci Tests

Major Companies Developing or Marketing Syphilis

Tests

Major Companies Developing or Marketing Toxoplasmosis

Tests

Major Companies Developing or Marketing Trichomonas

Tests

Major Companies Developing or Marketing Tuberculosis

Tests

Major Companies Developing or Marketing West Nile

Tests

Major Companies Developing or Marketing Yersinia Tests

Worldwide All Market Segments Laboratories

Performing Infectious Disease Tests by

Country

Worldwide All Market Segments Total Infectious

Disease Test Volume Forecast by Country

Worldwide All Market Segments Total Infectious

Disease Diagnostics Market Forecast by Country

Infectious Disease Tests Major Issues and Market

Potential For Personal Testing

France Summary Table

All Infectious Diseases Test Volume and Diagnostics Sales

Forecast by Market Segment

France

Laboratories Performing Infectious Disease Tests by Market

Segment

France

Hospital Laboratories Performing Infectious Disease

Tests by Bed Size

France

Commercial/Private Laboratories Performing Infectious

Disease Tests by Annual Test Volume

France

All Market Segments Infectious Disease Test Volume Forecast

France

Hospital Laboratories Infectious Disease Test Volume Forecast

France

Blood Banks Infectious Disease Test Volume Forecast

France

Commercial/Private Laboratories Infectious Disease

Test Volume Forecast

France

All Market Segments Infectious Disease Diagnostics

Market Forecast

France

Hospital Laboratories Infectious Disease Diagnostics

Market Forecast

France

Blood Banks Infectious Disease Diagnostics Market Forecast

France

Commercial/Private Laboratories Infectious Disease

Diagnostics Market Forecast

France

HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast

Forecast by Market Segment

France

HTLV I or HTLV I/HTLV II Test Volume and Diagnostics

Sales Forecast by Market Segment

France

HIV Ag Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Western Blot/Other Confirmatory Test Volume and

Diagnostics Sales Forecast by Market Segment

France

Adenovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Aeromonads Test Volume and Diagnostics Sales Forecast by

Market Segment

France

BEA Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Blastocystis Hominis Test Volume and Diagnostics

Sales Forecast by Market Segment

France

Campylobacter Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Candida Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Chancroid Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Chlamydia Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Clostridium Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Coronavirus Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Coxsackievirus Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Cryptosporidium Test Volume and Diagnostics Sales Forecast

by Market Segment

France

CMV Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Cyclospora Test Volume and Diagnostics Sales Forecast by

Market Segment

France

E. Coli Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Echovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Encephalitis Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Enterovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

France

EBV Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Giardia Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Gonorrhea Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Granuloma Inguinale Test Volume and Diagnostics

Sales Forecast by Market Segment

France

Hantavirus Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Helicobacter Pylori Test Volume and Diagnostics

Sales Forecast by Market Segment

France

HBsAg Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Hepatitis C Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Anti-HBc Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Anti-HBs Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Anti-HAV Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Hepatitis Delta Test Volume and Diagnostics Sales Forecast

by Market Segment

France

HAV NAT Test Volume and Diagnostics Sales Forecast

by Market Segment

France

HBV NAT Test Volume and Diagnostics Sales Forecast

by Market Segment

France

HBcAg Test Volume and Diagnostics Sales Forecast

by Market Segment

France

HBeAg Test Volume and Diagnostics Sales Forecast

by Market Segment

France

ALT/SGPT Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Herpes Simplex I and II Test Volume and Diagnostics

Sales Forecast by Market Segment

France

Herpes Type VI Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Influenza Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Legionella Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Lyme Disease Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Lymphogranuloma Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Malaria Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Measles Test Volume and Diagnostics Sales Forecast

by Market Segment

France

Meningitis Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Microsporidium Test Volume and Diagnostics Sales

Forecast by Market Segment

France

Mononucleosis Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Mumps Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Mycoplasma Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Papilloma Virus Test Volume and Diagnostics Sales

Forecast by Market Segment

France

Parvovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Pneumonia Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Polyoma Viruses Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Pseudomonas Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Rabies Test Volume and Diagnostics Sales Forecast by Market

Segment

France

RSV Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Rhinovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Rotavirus Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Rubella Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Salmonella Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Septicemia Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Shigella Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Staphylococci Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Streptococci Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Syphilis Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Toxoplasmosis Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Trichomonas Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Tuberculosis Test Volume and Diagnostics Sales Forecast by

Market Segment

France

Vibrio Test Volume and Diagnostics Sales Forecast by Market

Segment

France

Yersinia Test Volume and Diagnostics Sales Forecast by Market

Segment

France

AIDS Testing Market Diagnostics Sales by Major

Supplier

France

Adenovirus Testing Market Diagnostics Sales by

Major Supplier

France

Campylobacter Testing Market Diagnostics Sales by

Major Supplier

France

Candida Testing Market Diagnostics Sales by Major

Supplier

France

Chlamydia Testing Market Diagnostics Sales by Major

Supplier

France

CMV Testing Market Diagnostics Sales by Major

Supplier

France

Gonorrhea Testing Market Diagnostics Sales by Major

Supplier

France

Hepatitis Testing Market Diagnostics Sales by Major

Supplier

France

Hepatitis C Testing Market Diagnostics Sales by

Major Supplier

France

Herpes Testing Market Diagnostics Sales by Major

Supplier

France

Lyme Disease Testing Market Diagnostics Sales by

Major Supplier

France

Influenza Testing Market Diagnostics Sales by

Major Supplier

France

Meningitis Testing Market Diagnostics Sales by

Major Supplier

France

Mononucleosis Testing Market Diagnostics Sales by

Major Supplier

France

Mumps Testing Market Diagnostics Sales by Major

Supplier

France

Mycoplasma Testing Market Diagnostics Sales by Major

Supplier

France

RSV Testing Market Diagnostics Sales by Major Supplier

France

Rotavirus Testing Market Diagnostics Sales by Major

Supplier

France

Rubella Testing Market Diagnostics Sales by Major

Supplier

France

Septicemia Testing Market Diagnostics Sales by Major

Supplier

France

Shigella Testing Market Diagnostics Sales by Major

Supplier

France

Streptococci Testing Market Diagnostics Sales by

Major Supplier

France

Syphilis Testing Market Diagnostics Sales by Major

Supplier

France

Toxoplasmosis Testing Market Diagnostics Sales by

Major Supplier

France

Trichomonas Testing Market Diagnostics Sales by

Major Supplier

France

Tuberculosis Testing Market Diagnostics Sales by

Major Supplier

France

Infectious Disease Diagnostic Testing Instrumentation

Major Systems Estimated Placements and Installed Base

Germany Summary Table

All Infectious Diseases Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany

Laboratories Performing Infectious Disease Tests

Forecast by Market Segment

Germany

Hospital Laboratories Performing Infectious Disease

Tests by Bed Size

Germany

Commercial/Private Laboratories Performing Infectious

Disease Tests by Annual Test Volume

Germany

All Market Segments Infectious Disease Test Volume Forecast

Germany

Hospital Laboratories Infectious Disease Test Volume Forecast

Germany

Blood Banks Infectious Disease Test Volume Forecast

Germany

Commercial/Private Laboratories Infectious Disease

Test Volume Forecast

Germany

All Market Segments Infectious Disease Diagnostics

Market Forecast

Germany

Hospital Laboratories Infectious Disease Diagnostics

Market Forecast

Germany

Blood Banks Infectious Disease Diagnostics Market Forecast

Germany

Commercial/Private Laboratories Infectious Disease

Diagnostics Market Forecast

Germany

HIV or HIVI/HIVII Test Volume and Diagnostics Sales

Forecast by Market Segment

Germany

HTLV I or HTLV I/HTLV II Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany

HIV Ag Test Volume and Diagnostics Sales Forecast by Market

Segment

Germany

Western Blot/Other Confirmatory Test Volume and

Diagnostics Sales Forecast by Market Segment

Germany

Adenovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

Germany

Aeromonads Test Volume and Diagnostics Sales Forecast by

Market Segment

Germany

BEA Test Volume and Diagnostics Sales Forecast by Market

Segment

Germany

Blastocystis Hominis Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany

Campylobacter Test Volume and Diagnostics Sales Forecast by

Market Segment

Germany

Candida Test Volume and Diagnostics Sales Forecast by Market

Segment

Germany

Chancroid Test Volume and Diagnostics Sales Forecast by Market

Segment

Germany

Chlamydia Test Volume and Diagnostics Sales Forecast by Market

Segmen

To order this report:

In Vitro Diagnostic Industry: Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

__________________________

Contact Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Endovascular Surgical Interventions: Technology Market Penetration and Roadmapping
2. Reportlinker Adds Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
3. Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
4. Reportlinker Adds Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers
5. Reportlinker Adds Top Medical Devices and Imaging Technologies 2011
6. Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016
7. Reportlinker Adds UK CT Systems - Market Trend Till 2016
8. Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years
9. Reportlinker Adds US Cardiac Assist Devices -- Market Trend Till 2016
10. Reportlinker Adds Canada Medical Imaging - Market Projections to 2016
11. Reportlinker Adds US Cardiovascular Monitoring Systems - Market Trend Till 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ALSP, Inc. announced that it has appointed Col.(Retired) ... Affairs in preparation for its move into clinical trials with ... stated, "We are pleased to welcome Dallas Hack ... an individual of such practical knowledge and far-reaching experience in ... on his broad experience and success as a clinician and ...
(Date:2/10/2016)... 2016 Intouch Solutions, a leading marketing agency ... trend regarding the evolution of digital sales aids ... deliver compelling sales presentations via tablets. After conducting ... 2015, Intouch uncovered that while most pharmaceutical representatives ... many are not using them effectively during physician ...
(Date:2/10/2016)... -- Until recently, the options for reducing the appearance of ... approved the non-invasive Coolsculpting treatment, which removes fat cells ... in 2010 for the abdomen and this approval was ... this add-on approval, the experts at Laser Therapy Health ... CoolMini, to address smaller areas of fat. ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... ... Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - Time: 7:00pm ... 7:00pm – 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Workrite Ergonomics, ... company that has evolved from humble beginnings to being an internationally recognized leader in ... that we are today”, said Charlie Lawrence, President of Workrite. “Workrite recognized the ...
(Date:2/10/2016)... ... 2016 , ... Anxiety of older Americans over steep cost increases of prescription ... decade ago, according to The Senior Citizens League (TSCL). Since last ... with rapidly rising costs. “The implications are chilling, particularly for people with chronic ...
(Date:2/10/2016)... Puente, California (PRWEB) , ... February 09, 2016 ... ... Medicine students, faculty and staff helped give free oral screenings to 150 children ... Feb. 5, 2016. , The College of Dental Medicine joined Chinese American Dental ...
(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 09, 2016 , ... ... surgeons are witnessing a dramatic increase in the number of patients under the age ... reflects what they are seeing in their offices, and may indicate an overall shift ...
Breaking Medicine News(10 mins):